Pluristem Therapeutics announced the promising results of its non-human primates (NHP) pilot study for PLX-R18 as a treatment for Acute Radiation Syndrome (ARS).
List view / Grid view
Filter the results
22 June 2016 | By Victoria White, Digital Content Producer
Pluristem Therapeutics has reported positive data from preclinical studies of its PLX-PAD cells in the treatment of Duchenne muscular dystrophy...